tiprankstipranks
Trending News
More News >
MaaT Pharma (FR:MAAT)
:MAAT
France Market

MaaT Pharma (MAAT) Stock News & Sentiment

Compare
3 Followers
Promising ALS Trial Results Bolster Buy Rating for MaaT Pharma Amidst Strategic Oncology Focus
Premium
Ratings
Promising ALS Trial Results Bolster Buy Rating for MaaT Pharma Amidst Strategic Oncology Focus
8M ago
Buy Rating for MaaT Pharma Driven by Promising Clinical Developments and Strategic Financial Projections
Premium
Ratings
Buy Rating for MaaT Pharma Driven by Promising Clinical Developments and Strategic Financial Projections
9M ago
Buy Rating for MaaT Pharma: Promising Phase 3 Results and Strategic Growth Catalysts
Premium
Ratings
Buy Rating for MaaT Pharma: Promising Phase 3 Results and Strategic Growth Catalysts
9M ago

News Score - Last 7 Days

Neutral
FR:MAAT
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FR:MAAT’s Media Buzz Sentiment?
1 articles about FR:MAAT were published this week. In an average week, 1 articles are published.
    What is FR:MAAT’s weekly average amount of articles?
    In an average week, 1 articles about FR:MAAT are published.
      What is FR:MAAT’s News Sentiment?
      50% of articles about FR:MAAT were positive this week, compared to its sector average of 59%.
        Healthcare Stocks that are Trending in the News
        RVMDRevolution Medicines
        REGNRegeneron
        KRYSKrystal Biotech
        GNPXGenprex
        RIGLRigel
        Showing the stocks with the most bullish news sentiment over the past week